Loretta K. Allotey

发表

Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033))

Steven J. M. Jones, Chris Sander, Li Ding, 2017 .

Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular–clinical analysis and potential targeted approach

K. Ahn, J. Kocher, K. Kang, 2019, Hepatology International.

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.

M. Barrett, M. Borad, C. Moser, 2016, Cancer letters.

High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence

W. Harmsen, N. Giama, L. Roberts, 2022, World journal of gastroenterology.

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score

G. Gores, J. Marrero, Ziding Feng, 2018, Cancer Epidemiology, Biomarkers & Prevention.

Knowledge, Attitudes, and Behaviors of Viral Hepatitis Among Recent African Immigrants in the United States: A Community Based Participatory Research Qualitative Study

C. Patten, N. Giama, L. Roberts, 2020, Frontiers in Public Health.

Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma

T. Therneau, W. Harmsen, N. Giama, 2015, Cancer medicine.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Chris Sander, Peter W. Laird, Chandra Sekhar Pedamallu, 2017, Cell reports.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.

Christopher A. Miller, Joshua M. Stuart, Richard A. Moore, 2017, Cell reports.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Richard A. Moore, Lisle E. Mose, David I Heiman, 2017, Cell reports.